NCT03664310

Brief Summary

Background: Anxiety and insomnia disorders are two of the most common and costly mental health conditions. These disorders are frequently comorbid, but current treatment approaches do not target both. To streamline treatment for these commonly comorbid conditions, a novel, computerized intervention was developed targeting a transdiagnostic factor, safety aids, which are cognitive or behavioral strategies individuals use to cope with distress associated with anxiety or insomnia, that paradoxically exacerbate symptoms. A randomized controlled trial was conducted to determine the acceptability and efficacy of this newly developed intervention. Method: Young adults (N = 61) with elevated anxiety and insomnia symptoms were randomized to receive the anxiety-insomnia intervention or a computerized control condition focused on general physical health behaviors. After the intervention, participants were followed up at one week and one month and completed self-report measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 12, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 6, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 10, 2018

Completed
Last Updated

February 1, 2021

Status Verified

January 1, 2021

Enrollment Period

9 months

First QC Date

September 6, 2018

Last Update Submit

January 27, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Safety Aid Scale

    safety aids. Total score (79-445). Higher score indicates worsened symptoms.

    Month 1

Secondary Outcomes (4)

  • Sleep Related Behavior Questionnaire

    Month 1

  • Penn State Worry Questionnaire

    Month 1

  • Dimensional Obsessive Compulsive Scale

    Month 1

  • Insomnia Severity Index

    Month 1

Study Arms (2)

FSET Anxiety and Sleep Treatment

EXPERIMENTAL

The FSET Anxiety and Sleep Treatment (FAST) is a brief, 45-minute computerized intervention that can be accessed by any device connected to the Internet. The majority of the information is delivered via text. The program contains some interactive features such as quizzes, which direct participants to content, personalized to the individual user (for example screenshots, see Figure 2). FAST contains four modules: motivation, psychoeducation, behavioral tools, and behavior change.

Other: FSET Anxiety and Sleep Treatment

Control

ACTIVE COMPARATOR

The control condition is the Physical Health Education Treatment (PHET) used in several of our laboratory's prior studies (Schmidt, Capron, Raines, \& Allan, 2014). PHET is also a 45-minute computerized intervention, including audio and visual features as well as comprehension quizzes.

Other: Control

Interventions

Computerized anxiety and insomnia intervention.

FSET Anxiety and Sleep Treatment
ControlOTHER

Physical health control

Control

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • SD above the mean in anxiety and insomnia symptoms
  • Interest in improving anxiety and sleep

You may not qualify if:

  • Participating in another clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anxiety and Behavioral Health Clinic

Tallahassee, Florida, 32306, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 6, 2018

First Posted

September 10, 2018

Study Start

August 1, 2017

Primary Completion

May 12, 2018

Study Completion

May 12, 2018

Last Updated

February 1, 2021

Record last verified: 2021-01

Locations